ACTOBIO THERAPEUTICS
ActoBio Therapeutics develops therapeutic agents that treat a number of diseases, primarily on disease areas with high unmet needs. It develops a new class of therapeutic agents called ActoBiotics, a targeted, microbe-based, specifically designed agents that locally provide potential disease-modifying therapeutics to treat a range of disorders, such as immune-related diseases. ActoBiotics is based on the safe food-grade bacterium, Lactococcus lactis, which is used in the making of cheeses and ot... her foods. Lactococcus lactis is engineered to develop specific therapeutic agents for delivery directly to the relevant tissue, thus making therapeutic applications across many diseases. This holds safer and more efficacious treatments than injectable agents. The company has a strong research and development pipeline with stage candidate in Phase IIb, and an extensive portfolio of candidates ready for clinical development across a wide range of potential indications. ActoBio Therapeutics was founded on 2006 and is headquartered in Ghent. Belgium.
ACTOBIO THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics Wellness
Founded:
2006-01-01
Address:
Ghent, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.actobio.com
Total Employee:
11+
Status:
Closed
Contact:
+32 9 277 11 77
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator Barracuda Networks
Similar Organizations
Akttyva Therapeutics
Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications.
Alma Bio Therapeutics
Alma goes one step further in the treatment of autoimmune diseases by using body’ own mechanims to restore the original immune balance.
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
CiMaas
CiMaas develops immunotherapy for cancer by optimally engaging the immune system.
Exponential Biotherapies
Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Mabylon AG
Biotech from the University of Zurich developing human antibodies to treat neurological diseases and severe allergies.
Monument Therapeutics
Monument Therapeutics develops products to treat serious diseases of the central nervous system.
Parvus Therapeutics
Parvus Therapeutics is a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Official Site Inspections
http://www.actobio.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ActoBio Therapeutics"
ActoBio Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ActoBio Therapeutics, Inc. of Germantown, MD. Get the latest business insights from Dun & Bradstreet.See details»
Precigen ActoBio - LinkedIn
Precigen ActoBio | 824 followers on LinkedIn. Pioneers in unique disease-modifying technology | Precigen ActoBio™ is a clinical stage biotechnology company pioneering a new class of …See details»
ActoBio Therapeutics - Craft
ActoBio Therapeutics is a biotechnology company that specializes in microbe-based therapeutic agents. It develops ActoBiotics Lactococcus lactis biopharmaceuticals aiming to treat diseases …See details»
Our Story | A New Vision - ACTO
Since our inception in 2014, ACTO has grown into a global Life Sciences SaaS provider headquartered in Toronto, Canada. Learn more about our history and mission.See details»
Where Proteins and Innovation Advance Biomedicine
A cornerstone enterprise of the global biopharma industry dedicated to helping customers overcome challenges from discovery to the clinical stage by delivering innovative life science solutions.See details»
ActoBio Therapeutics CEO and Key Executive Team | Craft.co
ActoBio Therapeutics's CEO of Precigen ActoBio is Pieter Rottiers. Other executives include Helen Sabzevari, President, CEO and Director; Donald Lehr, Chief Legal Officer and 12 …See details»
ActoBio Therapeutics, Inc. - VentureRadar
Website: https://www.actobio.com/ Develops ActoBiotics®, microbe-based therapeutic agents for immune-related diseases, using food-grade bacterium Lactococcus lactis ...See details»
Novel Drug Development Opportunities in Autoimmune Diseases ...
ACROBiosystems has developed a series of high-quality recombinant proteins, functional cell lines, antibody-conjugated magnetic beads, and antibodies targeting various targets related to …See details»
ActoBio Therapeutics™ Doses First Patient in Phase Ib/IIa
Oct 29, 2018 A unique approach to induce immune tolerance using specifically targeted and designed ActoBiotics® Lactococcus lactis engineered to express therapeutic agents. GHENT, …See details»
Precigen ActoBio - Products, Competitors, Financials, Employees ...
Precigen ActoBio is a clinical stage biotechnology company focused on developing a new class of therapeutic agents in the healthcare sector. Use the CB Insights Platform to explore Precigen …See details»
Precigen Actobio - VentureRadar
Website: https://precigen.com/companies/precigen-actobio/ Develops microbe-based therapeutic agents for disease treatment using ActoBiotics™ technology, focusing on ...See details»
Acrobio
昇橋健康．專業信賴的最佳品牌. 以誠信務實的態度，整合中西醫學之專業. 昇橋健康投入醫療相關的機能性、養生保健食品之處方設計與產品研發，建立醫療通路的專業品牌，並藉由開創中西 …See details»
Intelligent Field Excellence Platform for Life Sciences | ACTO
ACTO is a Life Sciences Intelligent Field Excellence platform that improves brand performance by ensuring reps are always competent and confident in HCP interactions.See details»
ACROBiosystems - Crunchbase Company Profile & Funding
GlobeNewswire News Room — PD-L1 Biomarker Testing Market Review 2020-2024 and Growth Forecast 2025-2030 - Market to Reach USD 1.20 Billion by 2030, Driven by Immunotherapy …See details»
Acrobio healthcare Co., Ltd.
Acrobio selects plants and herbals which can be food materials to design products. Combining traditional herbal medicine with western's to assist modern medicine in solving problems that …See details»
Actobio - Life Science Animation
Life Science Animation presents Actobio medical animation. Visit our website and see how we help companies explain their science!See details»
Key Raw Materials for Cell and Gene Therapy - ACROBiosystems
What To Consider When Selecting a Raw Material Supplier. Finding the right supplier is the same as finding a partner. Evaluating potential supplier’s capabilities to supporting your process is …See details»
Acrobio | Animal Shelter
Acrobio Animal and Vet has provided us with high-quality supplements that cater to the specific requirements of each species. Their products have been instrumental in improving the health …See details»
昇橋健康事業有限公司 - acrobio.com
昇橋介紹. 日昇虹橋．生醫標竿. 從2002年創立至今，昇橋健康事業逐步穩健的寫下第一個精采的二十年。創辦人 林藥師 秉持對生命關懷的主張開發產品，以順應天然來源的方式來增進人類的 …See details»